• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Halozyme Therapeutics - Articles and news items

First patient dosed in Halozyme’s PEGPH20 pancreatic cancer trial

Industry news / 17 March 2016 / Victoria White

The trial will study PEGPH20 in combination with nab-paclitaxel and gemcitabine in patients with tumours that accumulate high levels of hyaluronan…

Eisai and Halozyme to investigate Halaven and PEGPH20 in metastatic breast cancer

Industry news / 31 July 2015 / Victoria White

Eisai and Halozyme are to collaborate to evaluate Halaven in combination with PEGPH20 in first line HER2-negative metastatic breast cancer…